Alti Global, Inc. (ALTI) Stock Price & Analysis
Alti Global, Inc. (ALTI) fell 21.87% to USD 3 as of September 8, 2026 at 10:17 UTC, according to Nexqual real-time market data.
ALTI last closed at USD 3.84; the session ranged USD 2.99–3.88 on volume of 1,433,430 shares. Market capitalization is $467.83M, with a 52-week range of USD 2.75–5.45 (NCM). Source: Nexqual, September 8, 2026 at 10:17 UTC.
Key Statistics (as of September 8, 2026 at 10:17 UTC)
| Price | USD 3 |
|---|---|
| Change | ▼ 21.87% (down) |
| Previous Close | USD 3.84 |
| Open | USD 3.8 |
| Day Range | USD 2.99 – 3.88 |
| 52-Week Range | USD 2.75 – 5.45 |
| Volume | 1,433,430 shares |
| Market Cap | $467.83M |
| Exchange | NCM |
Technical Analysis (ALTI)
Nexqual's technical model rates ALTI "SELL" based on 3 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 10:17 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.89 (oversold) |
| vs SMA50 | Below (USD 3.79) |
| MACD | -0.05 (negative) |
Earnings (ALTI)
| Next Earnings Date | 2026-11-09 |
|---|---|
| EPS Estimate | USD 0.02 |
| Revenue Estimate | $65.80M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0 vs est 0.06 ▼ miss |
| 2026-03-31 | USD 0.08 vs est 0.06 ▲ beat |
| 2025-12-31 | USD 0.1 vs est 0.02 ▲ beat |
| 2025-09-30 | USD 0.01 vs est 0.03 ▼ miss |
Source: Nexqual, September 8, 2026 at 10:17 UTC.
Financials & Fundamentals (ALTI)
| Total Revenue | $276.62M |
|---|---|
| Revenue Growth (YoY) | +10.80% |
| Gross Margin | +28.05% |
| Operating Margin | -18.70% |
| Profit Margin | -40.86% |
| ROE | -13.35% |
| Debt / Equity | 8.74 |
| Current Ratio | 1.16 |
| Total Cash | $31.20M |
| Total Debt | $75.85M |
| Free Cash Flow | $29.84M |
Source: Nexqual, September 8, 2026 at 10:17 UTC.
Ownership (ALTI)
| Insider Ownership | +53.19% |
|---|---|
| Institutional Ownership | +15.96% |
| Shares Outstanding | 115.07M |
| Float | 52.45M |
| Short % of Float | +2.44% |
Source: Nexqual, September 8, 2026 at 10:17 UTC.
From Alti Global, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- We have offices located in 19 leading financial centers, in 9 countries across the U.S., Europe and Asia, which enables us to service our clients across multiple jurisdictions.
- Our global distribution platform in our alternatives business also enables us to reach clients across three continents.
- We expect to continue to diligently evaluate and execute inorganic opportunities which will enhance our platform by broadening our global footprint or enabling us to expand our product offerings.
Partnerships
- Strategic Partners - Allianz and Constellation In February 2024, we announced our strategic relationship with Allianz and Constellation, for a combined investment of up to $450 million into AlTi.
- We also provide our wealth management clients with access to alternative investment opportunities, including investments in strategies and asset classes to which they would otherwise likely not be able to gain exposure.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SLSN | Solesence, Inc. | USD 0.85 | ▼ 6.7% |
| NGEN | NervGen Pharma Corp. | USD 2.33 | ▲ 0% |
| NVEC | NVE Corporation | USD 100.4 | ▲ 1.93% |
| ACCL | Acco Group Holdings Limited | USD 2.74 | ▲ 0% |
| VECO | Veeco Instruments Inc. | USD 44.67 | ▲ 3.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:17 UTC. This page is informational and not investment advice.